J E Epstein - JoVE Visualize

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Hearing Research|October 1, 1995

Secretion of a new basal layer of tectorial membrane following gentamicin-induced hair cell lossJ E Epstein, D A Cotanche

Annals of the Rheumatic Diseases|September 1, 1995

Rheumatic fever: autoantibodies against a variety of cardiac, nuclear, and streptococcal antigensQ G Eichbaum, E J Hughes, J E Epstein, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990

Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complexA Karpas, I K Hewlett, F Hill, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1994

Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progressionR W Veltri, A W Partin, J E Epstein, et al.

Infection and Immunity|July 12, 2001

Mannan-binding lectin enhances susceptibility to visceral leishmaniasisI K Santos, C H Costa, H Krieger, et al.

Vaccine|March 4, 2000

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteersT P Le, K M Coonan, R C Hedstrom, et al.

Genes and Immunity|August 20, 2004

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.

Infection and Immunity|September 22, 2006

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challengeS J Dunachie, M Walther, J E Epstein, et al.

Science (New York, N.Y.)|September 10, 2011

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.

Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Hearing Research|October 1, 1995

Secretion of a new basal layer of tectorial membrane following gentamicin-induced hair cell lossJ E Epstein, D A Cotanche

Annals of the Rheumatic Diseases|September 1, 1995

Rheumatic fever: autoantibodies against a variety of cardiac, nuclear, and streptococcal antigensQ G Eichbaum, E J Hughes, J E Epstein, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990

Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complexA Karpas, I K Hewlett, F Hill, et al.

Journal of Cellular Biochemistry. Supplement|January 1, 1994

Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progressionR W Veltri, A W Partin, J E Epstein, et al.

Infection and Immunity|July 12, 2001

Mannan-binding lectin enhances susceptibility to visceral leishmaniasisI K Santos, C H Costa, H Krieger, et al.

Vaccine|March 4, 2000

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteersT P Le, K M Coonan, R C Hedstrom, et al.

Genes and Immunity|August 20, 2004

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.

Infection and Immunity|September 22, 2006

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challengeS J Dunachie, M Walther, J E Epstein, et al.

Science (New York, N.Y.)|September 10, 2011

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunityJ E Epstein, K Tewari, K E Lyke, et al.

Pageof 1